Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways February 2024

The EU's proposed product liability directive portends potentially significant risk to medtechs that market their products in Europe; FDA's game plan for its one-year chairmanship of the International Medical Device Regulators Forum management committee; Siemens pushes lawmakers hard for more predictable reimbursement of AI-based tools; MDMA's Mark Leahey on the year ahead in medtech; and practical go-to-market tips from US, EU and UK regulatory experts.

Read Article